Form 4: GE HealthCare Director William Stromberg Boosts Stake Through Equity Compensation

GE HealthCare Technologies Inc. Director William J. Stromberg has increased his beneficial ownership in the company by acquiring 5,129 shares through restricted stock units and deferred stock units as part of his compensation.

Summary

• On May 28, 2025, William J. Stromberg, a Director of GE HealthCare Technologies Inc. (GEHC), acquired a total of 5,129 shares of the company's common stock.
• This acquisition included 3,092 restricted stock units (RSUs) which will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Additionally, Mr. Stromberg received 2,037 fully vested deferred stock units (DSUs) in lieu of a cash retainer, as per his election under GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
• Each RSU and DSU represents the right to receive one share of GE HealthCare common stock.
• Following these transactions, Mr. Stromberg's direct beneficial ownership in GE HealthCare Technologies Inc. increased to 14,330 shares.

Sentiment

Score: 7

Explanation: The sentiment is positive as a director is increasing their stake in the company, aligning their interests with shareholders. While these are compensation awards rather than open market purchases, the election of deferred stock units over cash further indicates confidence in the company's future.

Positives

• Director William J. Stromberg increased his beneficial ownership in GE HealthCare by 5,129 shares, which aligns his financial interests more closely with those of the company's shareholders.
• The election by the director to receive 2,037 fully vested deferred stock units instead of a cash retainer demonstrates a commitment to and confidence in the long-term value and performance of GE HealthCare.

Future Outlook

The 3,092 restricted stock units awarded to Director William J. Stromberg are set to vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026. Settlement of vested restricted stock units and deferred stock units will occur pursuant to the reporting person's applicable deferral election.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, a common practice across publicly traded companies where non-employee directors receive equity awards to align their interests with shareholders. Such filings provide transparency into insider holdings and compensation structures within the healthcare technology sector.

Stakeholder Impact

• Shareholders may view the increased director ownership positively, as it aligns the director's financial interests with the company's performance and long-term value creation.

Next Steps

• Vesting of 3,092 restricted stock units on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
• Settlement of vested restricted stock units and deferred stock units will occur pursuant to the reporting person's applicable deferral election.

Key Dates

Keywords

GE HealthCare, GEHC, Form 4, Insider Transaction, Director Stock Acquisition, Restricted Stock Units, Deferred Stock Units, Executive Compensation, Stock Ownership